Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale President and CEO sold 4,781 shares at $15.70 ($75,062)
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale 10% owner sold 28,357 shares at $16.36 ($463,793)
  4. 4 Exercise or conversion Chief Financial Officer acquired 3,000 shares (option exercise)
  5. 4 Open-market sale President and CEO sold 9,562 shares at an average $17.22 ($164,658)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Other disposition Director disposed of 750,000 shares (other)
  9. 4 Open-market sale 10% owner sold 1,650,000 shares at an average $17.39 ($28,700,395)
  10. 4 Open-market sale Director sold 0 shares
  11. 4 Open-market sale Chief Financial Officer sold 21,517 shares at an average $19.81 ($426,340)
  12. 4 Open-market sale President and CEO sold 14,343 shares at $19.60 ($281,123)
  13. 4 Other disposition 10% owner disposed of 850,000 shares (other)
  14. 4 Exercise or conversion Chief Financial Officer acquired 2,500 shares (option exercise)
  15. 4 Open-market sale President and CEO sold 14,343 shares at $15.00 ($215,145)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 20 · 400 filings